Skip to content

13F-HR filed by Kynam Capital Management, LP

Kynam Capital Management, LP filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 17:00:35 UTC, with 34 holding rows worth $1,806,156,492.

Accession
0001907884-26-000017
Filed
2026-11-16
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

13F report for Q3 2026

A holdings report, 34 entries on the cover page, a total value of $1,806,156,492 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,806,156,492 with VALUE read as dollars as filed, 13F file number 028-21939. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
LEGEND BIOTECH CORP52490G102SPONSORED ADS9,154,389$182,080,797dollars as filed
CELLDEX THERAPEUTICS INC NEW15117B202COM NEW5,066,051$164,190,713dollars as filed
SYNDAX PHARMACEUTICALS INC87164F105COM8,150,959$153,238,029dollars as filed
VAXCYTE INC COM92243G108Stock2,607,964$148,393,152dollars as filed
VIRIDIAN THERAPEUTICS INC92790C104COM6,148,000$126,587,320dollars as filed
COGENT BIOSCIENCES INC19240Q201COM3,792,289$121,429,094dollars as filed
TRAVERE THERAPEUTICS INC89422G107COM2,000,000$117,760,000dollars as filed
UROGEN PHARMA LTDM96088105COMMON STOCK2,434,207$98,901,830dollars as filed
VERA THERAPEUTICS INC92337R101COMMON STOCK3,000,000$96,870,000dollars as filed
BEAM THERAPEUTICS INC07373V105COM3,933,894$96,183,708dollars as filed
CYTOMX THERAPEUTICS INC23284F105COMMON STOCK21,140,726$57,502,775dollars as filed
MBX BIOSCIENCES INC COM55287L101Stock934,799$54,797,917dollars as filed
SUMMIT THERAPEUTICS INC86627T108COM3,000,000$50,730,000dollars as filed
RELAY THERAPEUTICS INC COM75943R102Stock2,751,500$49,664,575dollars as filed
CULLINAN THERAPEUTICS INC230031106COM3,114,132$47,801,926dollars as filed
IMMUNOCORE HLDGS PLC ADS45258D105ADR1,375,000$41,648,750dollars as filed
NURIX THERAPEUTICS INC67080M103COMMON STOCK1,194,757$28,327,688dollars as filed
PHARVARIS NVN69605108COMMON STOCK824,843$26,164,020dollars as filed
BURNING ROCK BIOTECH LTD-ADR12233L206SPONSORED ADS1,238,563$21,835,866dollars as filed
BIOCRYST PHARMACEUTICALS INC COM09058V103Stock2,522,660$21,013,758dollars as filed
SURROZEN INC86889P208COMMON STOCK486,252$15,647,589dollars as filed
SUTRO BIOPHARMA INC869367201COMMON STOCK872,558$14,056,909dollars as filed
XENON PHARMACEUTICALS INC COM98420N105Stock280,000$10,413,200dollars as filed
EVOMMUNE INC30054Y107COMMON STOCK1,200,000$9,912,000dollars as filed
PRELUDE THERAPEUTICS INC74065P101CMN2,311,955$9,039,744dollars as filed
GERON CORP374163103COM6,836,318$8,408,671dollars as filed
PARABILIS MEDICINES INC COM698955101Stock250,000$8,072,500dollars as filed
ALECTOR INC014442107COMMON STOCK4,308,494$7,970,714dollars as filed
AMARIN CORP PLC023111404SPONSORED ADR532,982$6,928,766dollars as filed
HARROW INC415858109COM124,655$3,839,374dollars as filed
CARIBOU BIOSCIENCES INC COM142038108Stock2,503,302$3,179,194dollars as filed
PROQR THERAPEUTICS NVN71542109SHS EURO1,566,317$2,600,086dollars as filed
ENGENE THERAPEUTICS INC29286X101COM457,855$915,710dollars as filed
TRAWS PHARMA INC68232V884COM NEW84,400$50,117dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001907884-26-000017this filing2026-11-16